Lipid Levels in the Post-Acute Coronary Syndrome Setting. Destabilizing Another Myth?**Editorials published in the Journal of the American College of Cardiology reflect the views of the authors and do not necessarily represent the views of JACC or the American College of Cardiology.

Journal of the American College of Cardiology

Volumn 51, Issue 15, 2008, Pages 1446-1447

  Miller, Michael ^a  

^a UNIVERSITY OF MARYLAND MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ROSUVASTATIN; VERY LOW DENSITY LIPOPROTEIN;

ACUTE CORONARY SYNDROME; BLOOD SAMPLING; CARDIOVASCULAR RISK; EDITORIAL; HUMAN; LIFESTYLE MODIFICATION; LIPID BLOOD LEVEL; MEDICAL PRACTICE; MEDICAL RESEARCH; PRIORITY JOURNAL;

ACUTE CORONARY SYNDROME; ANGINA, UNSTABLE; ANTICHOLESTEREMIC AGENTS; CHOLESTEROL, LDL; FLUOROBENZENES; HEPTANOIC ACIDS; HUMANS; PROGNOSIS; PYRIMIDINES; PYRROLES; SULFONAMIDES; TIME FACTORS;

EID: 41549104587     PISSN: 07351097     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jacc.2007.12.039     Document Type: Editorial

References (27)

1. Futterman L.G., and Lemberg L. Fifty percent of patients with coronary artery disease do not have any of the conventional risk factors. Am J Crit Care 7 (1998) 240-244
2. Magnus P., and Beaglehole R. The real contribution of the major risk factors to the coronary epidemics: time to end the "only-50%" myth. Arch Intern Med 161 (2001) 2657-2660
3. Greenland P., Knoll M.D., Stamler J., et al. Major risk factors as antecedents of fatal and nonfatal coronary heart disease events. JAMA 290 (2003) 891-897
4. Khot U.N., Khot M.B., Bajzer C.T., et al. Prevalence of conventional risk factors in patients with coronary heart disease. JAMA 290 (2003) 898-904
5. Pitt B., Loscalzo J., Yčas J., and Raichlen J.S. Lipid levels after acute coronary syndromes. J Am Coll Cardiol 51 (2008) 1440-1445
6. Biorck G., Blomqvist G., and Sievers J. Cholesterol values in patients with myocardial infarction and in a normal control group. Acta Med Scand 156 (1957) 493-497
7. Dodds C., and Mills G.L. Influence of myocardial infarction on plasma-lipoprotein concentration. Lancet 1 (1959) 1160-1163
8. Tibblin G., and Cramer K. Serum lipids during the course of an acute myocardial infarction and one year afterwards. Acta Med Scand 174 (1963) 451-455
9. Fyfe T., Baxter R.H., Cochran K.M., and Booth E.M. Plasma-lipid changes after myocardial infarction. Lancet 2 (1971) 997-1001
10. Kirkeby K. Disturbances in serum lipids and in their fatty acid composition following acute myocardial infarction. Acta Med Scand 192 (1972) 523-528
11. Ryder R.E., Hayes T.M., Mulligan I.P., et al. How soon after myocardial infarction should plasma lipid values be assessed?. BMJ 289 (1984) 1651-1653
12. Genest J.J., Corbett H.M., McNamara J.R., et al. Effect of hospitalization on high-density lipoprotein cholesterol in patients undergoing elective coronary angiography. Am J Cardiol 61 (1988) 998-1000
13. Nawaz H., Comerford B.P., Njike V.Y., et al. Repeated serum lipid measurements during the peri-hospitalization period. Am J Cardiol 98 (2006) 1379-1382
14. Pfohl M., Schreiber I., Liebich H.M., Häring H.U., and Hoffmeister H.M. Upregulation of cholesterol synthesis after acute myocardial infarction-is cholesterol a positive acute phase reactant?. Atherosclerosis 142 (1999) 389-393
15. Van Lenten B.J., Reddy S.T., Navab M., and Fogelman A.M. Understanding changes in high density lipoproteins during the acute phase response. Arterioscler Thromb Vasc Biol 26 (2006) 1687-1688
16. Large V., Peroni O., Letexier D., Ray H., and Beylot M. Metabolism of lipids in human white adipocyte. Diabetes Metab 30 (2004) 294-309
17. Austin M.A., King M.C., Vranizan K.M., and Krauss R.M. Atherogenic lipoprotein phenotype. A proposed genetic marker for coronary heart disease risk. Circulation 82 (1990) 495-506
18. Mulder M., Lombardi P., Jansen H., et al. Low density lipoprotein receptor internalizes low density and very low density lipoproteins that are bound to heparan sulfate proteoglycans via lipoprotein lipase. J Biol Chem 268 (1993) 9369-9375
19. Day J.L., Metcalfe J., and Simpson C.N. Adrenergic mechanism in control of plasma lipid concentrations. Br Med J 284 (1982) 1145-1148
20. Miller M., Bachorik P.S., and Cloey T.A. Normal variation of plasma lipoproteins: postural effects on plasma concentrations of lipids, lipoproteins, and apolipoproteins. Clin Chem 38 (1992) 569-574
21. Sacks F.M., and Katan M. Randomized clinical trials on the effects of dietary fat and carbohydrate on plasma lipoproteins and cardiovascular disease. Am J Med 113 Suppl 9B (2002) 13S-24S
22. Anderson J.L., Adams C.D., Antman E.M., et al. ACC/AHA 2007 guidelines for the management of patients with unstable angina/non-ST-elevation myocardial infarction: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines (Writing Committee to Revise the 2002 Guidelines for the Management of Patients With Unstable Angina/Non-ST-Elevation Myocardial Infarction). J Am Coll Cardiol 50 (2007) e1-e157
23. Rauoof M.A., Iqbal K., Mir M.M., and Tramboo N.A. Measurement of plasma lipids in patients admitted with acute myocardial infarction or unstable angina pectoris. Am J Cardiol 88 (2001) 165-167
24. Henkin Y., Crystal E., Goldberg Y., et al. Usefulness of lipoprotein changes during acute coronary syndromes for predicting postdischarge lipoprotein levels. Am J Cardiol 89 (2002) 7-11
25. Cannon C.P., Braunwald E., McCabe C.H., et al., Pravastatin or Atorvastatin Evaluation and Infection Therapy-Thrombolysis in Myocardial Infarction 22 Investigators. Intensive versus moderate lipid lowering with statins after acute coronary syndromes. N Engl J Med 350 (2004) 1495-1504
26. Grundy S.M., Cleeman J.I., Merz C.N., et al., Coordinating Committee of the National Cholesterol Education Program. Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III Guidelines. J Am Coll Cardiol 44 (2004) 720-732
27. Rasmussen J.N., Chong A., and Alter D.A. Relationship between adherence to evidence-based pharmacotherapy and long-term mortality after acute myocardial infarction. JAMA 297 (2007) 177-186